Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Oct;22(10):1939-45.
doi: 10.1681/ASN.2010121306. Epub 2011 Aug 18.

Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis

Affiliations
Randomized Controlled Trial

Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis

Rodrigo Peixoto Campos et al. J Am Soc Nephrol. 2011 Oct.

Abstract

There is growing concern about the development of antibacterial resistance with the use of antibiotics in catheter lock solutions. The use of an antibiotic that is not usually used to treat other serious infections may be an alternative that may reduce the clinical impact should resistance develop. We conducted a randomized controlled trial to compare a solution of minocycline and EDTA with the conventional unfractionated heparin for the prevention of catheter-related bacteremia in hemodialysis patients during a period of 90 d. The study included 204 incident catheters (27.8% tunneled); 14 catheters were excluded because of early dysfunction and 3 because of protocol violations. We observed catheter-related bacteremia in 19 patients in the heparin group (4.3 per 1000 catheter-days) and in 5 patients in the minocycline-EDTA group (1.1 per 1000 catheter-days; P = 0.005). We did not detect a significant difference in the rate of catheter removal for dysfunction. Catheter-related bacteremia-free survival was significantly higher in the minocycline-EDTA group than in the heparin group (P = 0.005). In conclusion, a minocycline-EDTA catheter lock solution is effective in the prevention of catheter-related bacteremia in hemodialysis patients.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Randomization and follow-up.
Figure 2.
Figure 2.
Kaplan-Meier analysis of the probability that patients would remain free of catheter-related bacteremia (CRB) for all catheters.
Figure 3.
Figure 3.
Kaplan-Meier analysis of the probability that patients would remain free of catheter-related dysfunction for all catheters.
Figure 4.
Figure 4.
Kaplan-Meier analysis of the probability that patients would remain free of catheter-related bacteremia and dysfunction for all catheters.

Comment in

References

    1. Rayner HC, Pisoni RL: The increasing use of hemodialysis catheters: Evidence from the DOPPS on its significance and ways to reverse it. Semin Dial 23: 6–10, 2010 - PubMed
    1. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 23: 3219–3226, 2008 - PMC - PubMed
    1. Fry AC, Stratton J, Farrington K, Mahna K, Selvakumar S, Thompson H, Warwicker P: Factors affecting long-term survival of tunnelled haemodialysis catheters–A prospective audit of 812 tunnelled catheters. Nephrol Dial Transplant 23: 275–281, 2008 - PubMed
    1. Lemaire X, Morena M, Leray-Moragues H, Henriet-Viprey D, Chenine L, Defez-Fougeron C, Canaud B: Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif 28: 21–28, 2009 - PubMed
    1. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK: Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 53: 475–491, 2009 - PubMed

Publication types